Nonclostridial myonecrosis, 307–308
Non-HACEK gram-negative bacilli, IE and, 221
Nonsteroidal anti-inflammatory drugs (NSAIDs), 303
Nosocomial fevers of unknown origin (FUOs), 8
Nosocomial infections, 521
risk factors for acquisition of, in adults, 107
sites of infection due to, in NICU, 104
standard precautions, 433
Nosocomial pneumonia (NP), 345, 514.See also
Hospital-acquired pneumonia (HAP);
Ventilator-associated pneumonia (VAP)
risk factors for, 346
Nosocomial pneumonia (NP)/
Ventilator-associated pneumonia
(NP/VAP), 14–15
Nosocomial urosepsis, 288–289
NP.SeeNosocomial pneumonia (NP)
NP/VAP.SeeNosocomial pneumonia/
Ventilator-associated pneumonia
NSAIDs.SeeNonsteroidal anti-inflammatory
drugs (NSAIDs)
Nuchal biopsy, 481
Nuchal rigidity, physical findings
diagnostic features, 61
noninfectious mimics, 61
Nuclear scintigraphy, 83
Nutritionally variant streptococci.See Abiotrophiaspp.
NVIE.SeeNative valve IE (NVIE)
Nystatin, 362
Obturator sign, physical findings
diagnostic features, 59
noninfectious mimics, 59
Occipital lymphadenopathy, physical findings
diagnostic features, 55
noninfectious mimics, 55
Ochrobactrum anthropi, 302
Oculoglandular.SeeTularemia (oculoglandular)
Oculoglandular tularemia, 478
OKT3 monoclonal antibody, 400
OLT.SeeOrthotopic liver transplantation (OLT)
Optic atrophy, 72
Optic neuritis, 68
Optic papillitis, physical findings
diagnostic features, 51–52
noninfectious mimics, 51–52
Organ system
miliary tuberculosis and, 423
Organ transplantation, infection in.SeeSolid-organ
transplant (SOT)
Oritavancin, 193, 316
Oropharyngeal pathogen aspiration, 179
Oropharyngeal tularemia, 478
Orthopnea, physical findings
diagnostic features, 50
noninfectious mimics, 50
Orthotopic liver transplantation (OLT), 388
recipients
BSIs in, 403
intra-abdominal infection in, 397
Osler’s nodes, and SBE/ABE, 27
Overwhelming postsplenectomy infection
(OPSI)
antimicrobial therapy, 353–354
chemoprophylaxis, 355
clinical presentation, 352–353
diagnosis and management of, 353
educating patients, 354
immunoprophylaxis.SeeImmunoprophylaxis
prevention, 354
self-treatment of, 355–356
Oxacillin, 190Pacemaker IE (PMIE), 223, 227, 231.See also
Infective endocarditis (IE)
treatment of, 239
PAF.SeePlatelet-activating factor (PAF)
Palatal purpura, physical findings
diagnostic features, 53
noninfectious mimics, 53
Palatal ulcer, physical findings
diagnostic features, 53
noninfectious mimics, 53
Pancolitis
clinical and radiologic diagnosis of, 84
mimics of UC, 85
Pancreatitis, acute
diagnosis, 267
prophylaxis, 267–268
treatment, 267–268
Pancytopenia, 424
Pan-systolic murmur, physical findings
diagnostic features, 58
noninfectious mimics, 58
Panton-Valentine-leukocidin (PVL) genes, 103
toxin, 315, 370
Papulosquamous rash
on wrist and hands of patient with secondary
syphilis, 32
Parainfluenza virus, 181
Paralytic rabies, 480
Paraplegia, physical findings
diagnostic features, 63
noninfectious mimics, 63
Parotid enlargement, physical findings
diagnostic features, 52
enlargement and tenderness, 52
noninfectious mimics, 52
Pasteurellaspp.
from dog bites and cat bites, 301–302
Pathogens
direct inoculation with, VAP and, 180
inhalation of, 180
nonbacterial, 352
PBP2a.SeePenicillin-binding protein
2a (PBP2a)
PCR.SeePolymerase chain reaction (PCR)
PCT.SeeProcalcitonin (PCT)
PD.SeePharmacodynamic (PD) parameters
PE.SeePulmonary embolus (PE)Index 573